| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3191003 | Annals of Allergy, Asthma & Immunology | 2015 | 8 Pages |
Abstract
A good clinical response (â¥60% improvement in both TSS5 and quality of life) is associated with significant decreases in IL-5, IL-13, and IL-4 relative to IFN-γ during 2 years of SLIT therapy for HDMs.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Paul C. MD, MBChB, DCH, FCP, Sheila MSc, Bartha Dip Med Tech, Barbara PhD,